quinoxalines has been researched along with snx 482 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crair, MC; Komatsu, Y; Kurotani, T; Yamada, K; Yoshimura, Y | 1 |
| Myoga, MH; Regehr, WG | 1 |
2 other study(ies) available for quinoxalines and snx 482
| Article | Year |
|---|---|
State-dependent bidirectional modification of somatic inhibition in neocortical pyramidal cells.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Animals, Newborn; Bicuculline; Dendrites; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Inhibitory Postsynaptic Potentials; Neural Inhibition; Patch-Clamp Techniques; Pyramidal Cells; Quinoxalines; Rats; Rats, Sprague-Dawley; Spider Venoms; Visual Cortex | 2008 |
Calcium microdomains near R-type calcium channels control the induction of presynaptic long-term potentiation at parallel fiber to purkinje cell synapses.
Topics: Adenosine A1 Receptor Antagonists; Analysis of Variance; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Calcium Channels, R-Type; Calcium Signaling; Cerebellum; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; GABA Antagonists; In Vitro Techniques; Long-Term Potentiation; Membrane Microdomains; Neural Pathways; Nickel; omega-Agatoxin IVA; omega-Conotoxin GVIA; Patch-Clamp Techniques; Phosphinic Acids; Piperidines; Presynaptic Terminals; Propanolamines; Purkinje Cells; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Spider Venoms; Tetrodotoxin; Xanthines | 2011 |